SB198: directing the insurance department to conduct a cost study of providing coverage for certain reproductive health care.

SB 198 - AS INTRODUCED

2023 SESSION

23-0957

05/04

SENATE BILL 198

AN ACT directing the insurance department to conduct a cost study of providing coverage for certain reproductive health care.

SPONSORS: Sen. Perkins Kwoka, Dist 21; Sen. Soucy, Dist 18; Sen. D'Allesandro, Dist 20; Sen. Rosenwald, Dist 13; Sen. Fenton, Dist 10; Sen. Altschiller, Dist 24; Sen. Watters, Dist 4; Sen. Whitley, Dist 15; Sen. Prentiss, Dist 5; Rep. Simpson, Rock. 33; Rep. Grote, Rock. 24

COMMITTEE: Commerce

ANALYSIS

This bill directs the insurance department to conduct a study of the costs of expanding group health insurance coverage for same-sex couples and single individuals undergoing assisted reproduction treatment when the covered individual does not have a diagnosis of infertility.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

23-0957

05/04

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Twenty Three

AN ACT directing the insurance department to conduct a cost study of providing coverage for certain reproductive health care.

Be it Enacted by the Senate and House of Representatives in General Court convened:

1 Insurance Department; Cost Study; Reproductive Health Care. The insurance department shall conduct a study of the costs of expanding group health insurance coverage for same-sex couples and single individuals undergoing assisted reproduction treatment when the covered individual does not have a diagnosis of infertility, as defined in RSA 417-G:1, V.

I. The cost study shall consider, but not be limited to:

(a) The potential number of individuals being covered;

(b) The total costs of coverage for assisted reproduction treatment from the beginning of preconception diagnostic assessments and testing;

(c) Cost savings obtained from adherence to best practices as recommended by the American Society for Reproductive Medicine; and

(d) Coverage that includes:

(1) Diagnosis of any conditions that may impact the efficacy of the contemplated assisted reproduction treatment; and

(2) Medically necessary fertility treatment, including coverage for evaluations, laboratory assessments, medications, and medical costs associated with the procurement of eggs, sperm, and embryos.

II. The study shall be completed no later than December 31, 2023, and the results of the study shall be submitted to the governor, the president of the senate, the speaker of the house of representatives, and the chairpersons of the senate and house policy committees with relevant jurisdiction. The study also shall be posted on the department's website for public review.

2 Effective Date. This act shall take effect upon its passage.